Search Results - "Abuodeh, Yazan A."

Treatment delays, race, and outcomes in head and neck cancer by Naghavi, Arash O., MD, MS, Echevarria, Michelle I., MD, Strom, Tobin J., MD, Abuodeh, Yazan A., MD, Ahmed, Kamran A., MD, Venkat, Puja S., MD, Trotti, Andy, MD, Harrison, Louis B., MD, Green, B. Lee, PhD, Yamoah, Kosj, MD, PhD, Caudell, Jimmy J., MD, PhD

“…Highlights • Black patients more often presented with delays in diagnosis or advanced disease. • Black patients more often had >45 days elapsed from diagnosis…”
Get full text

Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy by Ahmed, Kamran A., MD, Caudell, Jimmy J., MD, PhD, El-Haddad, Ghassan, MD, Berglund, Anders E., PhD, Welsh, Eric A., PhD, Yue, Binglin, MS, Hoffe, Sarah E., MD, Naghavi, Arash O., MD, Abuodeh, Yazan A., MD, Frakes, Jessica M., MD, Eschrich, Steven A., PhD, Torres-Roca, Javier F., MD

“…Purpose/Objectives Evidence from the management of oligometastases with stereotactic body radiation therapy (SBRT) reveals differences in outcomes based on…”
Get full text

Low-Dose Rate Brachytherapy for Prostate Cancer in Low Resource Settings by Echevarria, Michelle I., MD, Naghavi, Arash O., MD MS, Abuodeh, Yazan A., MD, Ahmed, Kamran A, Chevere, Carlos, MD, Fernandez, Daniel, MD PhD, Yamoah, Kosj, MD PhD

“…Abstract Introduction In areas with limited healthcare, it is important to identify and implement effective treatment methods while optimizing available…”
Get full text

Patient choice for high‐volume center radiation impacts head and neck cancer outcome by Naghavi, Arash O., Echevarria, Michelle I., Strom, Tobin J., Abuodeh, Yazan A., Venkat, Puja S., Ahmed, Kamran A., Demetriou, Stephanie, Frakes, Jessica M., Kim, Youngchul, Kish, Julie A., Russell, Jeffery S., Otto, Kristen J., Chung, Christine H., Harrison, Louis B., Trotti, Andy, Caudell, Jimmy J.

“…Background Studies suggest treatment outcomes may vary between high (HVC)‐ and low‐volume centers (LVC). Radiation therapy (RT) for head and neck cancer (HNC)…”
Get full text

Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses by Abuodeh, Yazan A, Naghavi, Arash O, Juan, Tzu-Hua, Ma, Zhenjun, Wilder, Richard B

“…To evaluate quality of life (QoL) after post-prostatectomy intensity modulated radiation therapy (IMRT) in the "adjuvant" setting starting within 4 months of…”
Get full text

Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma by Naghavi, Arash O, Gonzalez, Ricardo J, Scott, Jacob G, Kim, Youngchul, Abuodeh, Yazan A, Strom, Tobin J, Echevarria, Michelle, Mullinax, John E, Ahmed, Kamran A, Harrison, Louis B, Fernandez, Daniel C

“…Adjuvant brachytherapy (AB) with immediate (IR) and staged reconstruction (SR) are distinct treatment modalities available for patients with recurrent soft…”
Get full text

Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies by Naghavi, Arash O., Echevarria, Michelle I., Grass, G. Daniel, Strom, Tobin J., Abuodeh, Yazan A., Ahmed, Kamran A., Kim, Youngchul, Trotti, Andy M., Harrison, Louis B., Yamoah, Kosj, Caudell, Jimmy J.

“…BACKGROUND Patients covered by Medicaid insurance appear to have poorer cancer outcomes. Herein, the authors sought to test whether Medicaid was associated…”
Get full text

The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy by Echevarria, Michelle I, Naghavi, Arash O, Venkat, Puja S, Abuodeh, Yazan A, Chevere, Carlos, Yamoah, Kosj

“…Low-dose-rate (LDR) brachytherapy has been established as an effective and safe treatment option for men with low and intermediate risk prostate cancer. In…”
Get full text

Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer Patients by Grass, G. Daniel, Naghavi, Arash O., Abuodeh, Yazan A., Perez, Bradford A., Dilling, Thomas J.

“…The appropriate follow-up frequency after chemoradiotherapy (CRT) for locally advanced non–small-cell lung cancer patients is unknown. Our data on 211 patients…”
Get full text

Management of Oropharyngeal Cancer in the HPV Era by Naghavi, Arash O, Strom, Tobin J, Ahmed, Kamran A, Echevarria, Michelle I, Abuodeh, Yazan A, Venkat, Puja S, Frakes, Jessica M, Harrison, Louis B, Trotti, Andy M, Caudell, Jimmy J

“…Historically, oropharyngeal cancer (OPC) has been attributed to risk factors such as smoking and alcohol use. The increased incidence of OPC has been driven by…”
Get more information

Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma by Naghavi, Arash O, Gonzalez, Ricardo J, Scott, Jacob G, Mullinax, John E, Abuodeh, Yazan A, Kim, Youngchul, Binitie, Odion, Ahmed, Kamran A, Bui, Marilyn M, Saini, Amarjit S, Zager, Jonathan S, Biagioli, Matthew C, Letson, Douglas, Harrison, Louis B, Fernandez, Daniel C

“…Abstract Purpose Prior studies illustrated a reduction in wound complications with the use of staged reconstruction (SR) and negative pressure wound therapy…”
Get full text

Viral hepatitis associated hepatocellular carcinoma outcomes with yttrium-90 radioembolization by Frakes, Jessica M, Abuodeh, Yazan A, Naghavi, Arash O, Echevarria, Michelle I, Shridhar, Ravi, Friedman, Mark, Kim, Richard, El-Haddad, Ghassan, Kis, Bela, Biebel, Benjamin, Sweeney, Jennifer, Choi, Junsung, Anaya, Daniel, Giuliano, Anna R, Hoffe, Sarah E

“…Viral associated (VA) malignancies have recently been correlated with improved outcomes. We sought to evaluate outcomes of patients with hepatocellular…”
Get full text

The Impact of BMI on Dosimetric Quality in Low Dose Rate Prostate Brachytherapy by Echevarria, Michelle I., MD, Naghavi, Arash O., MD, Abuodeh, Yazan A., MD, Chevere, Carlos M., MD, Yamoah, Kosj, MD, PhD

Get full text